硬式內視鏡市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、最終用戶、地區和競爭格局分類，2021-2031年）

全球硬式內視鏡市場預計將從 2025 年的 73.6 億美元成長到 2031 年的 106.8 億美元，年複合成長率為 6.41%。

這些由非彈性導管和光纖傳輸裝置組成的光學儀器，對於在腹腔鏡和關節鏡等微創手術中觀察體腔至關重要。市場成長的主要驅動力是縮短住院時間的外科技術發展趨勢以及需要醫療干預的慢性疾病病例的增加。例如，美國癌症協會估計，到2025年，美國將新增約2,041,910例癌症病例。如此沉重的疾病負擔正在推動泌尿系統和一般外科領域對精準可視化儀器的持續需求。

然而，可重複使用儀器的再處理及其相關的交叉感染風險，為市場帶來了許多障礙。為防止醫院感染而必須嚴格執行的消毒通訊協定，往往會造成操作上的挑戰和監管上的複雜性。此外，先進診斷影像系統所需的大量資金投入，也阻礙了其普及，尤其對於預算有限的醫療機構而言更是如此。

市場促進因素

機器人輔助內視鏡系統的日益普及正成為市場擴張的主要催化劑，因為這些平台高度依賴先進的硬式內視鏡，以在複雜的手術過程中提供3D視覺化。隨著醫療機構採用機器人技術來提高婦科、泌尿系統和一般外科的手術精度，這些光學儀器的使用量正在顯著成長。主要機器人系統供應商的業績也印證了這個趨勢。直覺外科公司（Intuitive Surgical）在2025年1月報告稱，到2024年，全球使用達文西手術系統進行的手術數量將達到約268.3萬例，比上一年成長17%。手術量的強勁成長凸顯了硬式內視鏡在現代機器人手術環境中發揮的關鍵作用。

同時，高畫質和3D成像技術的創新正在加速設備更新換代，並推動微創手術的應用。諸如4K影像等功能使外科醫生能夠更精準地識別病灶，從而改善臨床療效並提高工作流程效率。這為主要行業參與者帶來了顯著的經濟效益。例如，Olympus Corporation在2024年5月公佈，截至2024年3月的會計年度，其內視鏡解決方案業務銷售額達到5,866億日元，年增6.3%。此外，需要診斷干預的疾病發生率不斷上升，也給醫療資源帶來了壓力。根據英國國家醫療服務體系（NHS）2024年的數據，11月有19.9%的病患等待診斷檢測的時間超過六週，凸顯了對內視鏡技術的持續需求。

市場挑戰

先進的硬式內視鏡及相關診斷影像系統需要大量的資金投入，這構成了市場推廣的一大障礙。醫療機構通常面臨嚴格的預算限制，難以購買昂貴的醫療設備。當最新的視覺化工具需要高昂的前期成本時，醫院往往會推遲升級或繼續使用舊設備。這種對新技術投資的抵觸情緒直接限制了製造商的收入潛力，並減緩了先進內視鏡解決方案在全球市場的滲透速度。

不斷上漲的營運成本進一步加劇了這種財務壓力，營運成本佔了醫療保健預算成長的很大一部分。根據美國醫院協會 (AHA) 預測，到 2024 年，醫院總支出預計將增加 5.1%，遠超整體通貨膨脹率。這種經濟負擔迫使決策者優先考慮維持日常運營，而非對外科器械進行資本投資。因此，許多醫療機構無法負擔這些不斷上漲的成本，導致其購買力下降，並阻礙了整個硬式內視鏡市場的成長。

市場趨勢

隨著醫療服務提供者尋求更具成本效益的住院治療替代方案，內視鏡手術向門診手術中心（ASC）的轉移正在改變市場格局。這種轉變在關節鏡和腹腔鏡等硬式內視鏡手術中尤其明顯，門診手術中心精簡的工作流程能夠提高手術量並降低營運成本。有利的報銷政策以及專為小規模環境設計的緊湊型高性能視覺化系統的普及，進一步推動了這一轉變。正如門診手術中心協會在2024年7月指出的那樣，預計2024年至2034年間，門診手術中心的手術量將成長21%，達到4400萬例。這促使製造商積極開發針對不斷成長的門診領域的專業服務模式和設備。

同時，螢光引導成像系統的進步使外科醫生能夠比使用標準白光內視鏡更精確地觀察解剖結構。近紅外線螢光技術能夠即時評估組織灌注情況，並在複雜的腹腔鏡手術中識別膽管，從而推動了對這些先進光學功能的需求。這項技術革新滿足了提高術中安全性的迫切需求，並推動了領先設備製造商的收入成長。根據史賽克公司2025年1月發布的報告，該公司預計其內視鏡業務在2024會計年度將實現全球兩位數的有機銷售成長，這凸顯了整合螢光功能的下一代成像平台在改善臨床療效方面的加速普及。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球硬式內視鏡市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（腹腔鏡、關節鏡、輸尿管鏡、膀胱鏡、婦科內視鏡、神經內視鏡、神經科學用內視鏡、子宮鏡鏡、喉鏡、鼻竇鏡、耳鏡、乙狀結腸鏡、咽鏡、十二指腸鏡、鼻咽鏡、鼻內視鏡）
  • 按最終使用者（醫院/診所、門診護理中心、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美硬式內視鏡市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章 歐洲硬式內視鏡市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章 亞太地區硬式內視鏡市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲硬式內視鏡市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲硬式內視鏡市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球硬式內視鏡市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Olympus Corporation
• Ethicon, Inc.
• Boston Scientific Corporation
• Karl Storz SE & Co. KG
• Stryker Corporation
• PENTAX Medical Singapore Pte Ltd
• Richard Wolf GmbH
• ATMOS MedizinTechnik GmbH & Co. KG
• XION GmbH
• EndoMed Systems GmbH

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Rigid Endoscopes Market is projected to expand from a valuation of USD 7.36 Billion in 2025 to USD 10.68 Billion by 2031, reflecting a CAGR of 6.41%. These optical devices, which consist of a non-flexible tube and a light transmission mechanism, are essential for visualizing internal cavities during minimally invasive interventions like laparoscopy and arthroscopy. Market growth is largely sustained by a preference for surgical methods that reduce hospital stays and the increasing prevalence of chronic conditions requiring medical intervention. For instance, the American Cancer Society estimates that approximately 2,041,910 new cancer cases will occur in the United States in 2025. This substantial disease burden drives a persistent demand for accurate visualization instruments in urology and general surgery.

Nevertheless, the market encounters significant obstacles related to the reprocessing of reusable instruments and the associated danger of cross-contamination. Strict sterilization protocols needed to prevent hospital-acquired infections often create operational difficulties and regulatory complexities. Furthermore, the substantial capital expenditure required for advanced imaging systems presents a barrier to adoption, particularly for healthcare facilities that must operate within limited budgets.

Market Driver

The growing integration of robot-assisted endoscopic systems acts as a major catalyst for market expansion, as these platforms depend heavily on advanced rigid endoscopes to provide 3D visualization during complex procedures. As medical facilities adopt robotic technologies to improve surgical precision in gynecology, urology, and general surgery, the usage of these optical instruments has increased substantially. This trend is evident in the performance of major robotic system providers; Intuitive Surgical reported in January 2025 that roughly 2,683,000 surgical procedures were conducted globally using da Vinci systems in 2024, marking a 17% rise from the previous year. Such robust procedural growth highlights the essential role of rigid endoscopy within the modern robotic surgical landscape.

Simultaneously, innovations in high-definition and 3D imaging are accelerating device replacement cycles and adoption in minimally invasive surgeries. Features such as 4K visualization allow surgeons to identify pathologies with greater accuracy, thereby enhancing clinical outcomes and workflow efficiency, which has generated significant financial returns for key industry players. For example, Olympus Corporation reported in May 2024 that revenue in its Endoscopic Solutions Business hit ¥586.6 billion for the fiscal year ending March 31, 2024, a 6.3% year-on-year increase. Additionally, the rising incidence of disorders requiring diagnostic intervention strains healthcare resources; NHS England data from 2024 indicated that 19.9% of patients waited six weeks or more for diagnostic tests in November, emphasizing the continued need for endoscopic capacity.

Market Challenge

The substantial capital investment required for advanced rigid endoscopes and their accompanying imaging systems constitutes a major hurdle to market adoption. Healthcare facilities frequently function under strict budget limitations, restricting their ability to procure expensive medical capital equipment. When confronted with high upfront costs for modern visualization tools, hospitals often postpone upgrades or persist in using legacy devices. This hesitation to invest in new technology directly limits the revenue potential for manufacturers and slows the penetration of advanced endoscopic solutions in the global marketplace.

This financial pressure is exacerbated by rising operational costs that consume a growing portion of healthcare budgets. According to the American Hospital Association, total hospital expenses increased by 5.1% in 2024, significantly outpacing the general inflation rate. This economic strain compels decision-makers to prioritize essential daily operations over capital investments in surgical instrumentation. Consequently, the inability of many institutions to absorb these elevated costs reduces their purchasing power and hampers the overall growth of the rigid endoscopes market.

Market Trends

The migration of endoscopic procedures to Ambulatory Surgical Centers (ASCs) is reshaping the market landscape as providers seek cost-effective alternatives to inpatient care. This shift is particularly evident in rigid endoscopic interventions like arthroscopy and laparoscopy, where the streamlined workflows of ASCs facilitate higher throughput and lower overhead costs. Supportive reimbursement policies and the availability of compact, high-performance visualization systems designed for smaller environments further encourage this transition. As noted by the Ambulatory Surgery Center Association in July 2024, surgical procedure volume in ASCs is projected to rise by 21% to reach 44 million cases between 2024 and 2034, incentivizing manufacturers to create specialized service models and devices for the expanding outpatient sector.

Concurrently, the advancement of fluorescence-guided imaging systems is allowing surgeons to visualize anatomical structures with greater precision than standard white-light endoscopy affords. Technologies utilizing near-infrared fluorescence enable real-time assessment of tissue perfusion and bile duct identification during complex laparoscopic surgeries, driving demand for these sophisticated optical capabilities. This technological evolution addresses a critical need for improved intraoperative safety and is fueling revenue growth for major device manufacturers. According to Stryker Corporation's January 2025 report, the company's endoscopy business achieved double-digit organic sales growth globally for the full year 2024, highlighting the accelerating adoption of next-generation imaging platforms that integrate fluorescence capabilities to improve clinical outcomes.

Key Market Players

• Olympus Corporation
• Ethicon, Inc.
• Boston Scientific Corporation
• Karl Storz SE & Co. KG
• Stryker Corporation
• PENTAX Medical Singapore Pte Ltd
• Richard Wolf GmbH
• ATMOS MedizinTechnik GmbH & Co. KG
• XION GmbH
• EndoMed Systems GmbH

Report Scope

In this report, the Global Rigid Endoscopes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Rigid Endoscopes Market, By Product

• Laparoscopes
• Arthroscopes
• Ureteroscopes
• Cystoscopes
• Gynecology Endoscopes
• Neuroendoscopes
• Bronchoscopes
• Hysteroscopes
• Laryngoscopes
• Sinuscopes
• Otoscopes
• Sigmoidoscopes
• Pharygnoscopes
• Duodenoscopes
• Nasopharygnoscopes
• Rhinoscopes

Rigid Endoscopes Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Rigid Endoscopes Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Rigid Endoscopes Market.

Available Customizations:

Global Rigid Endoscopes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Rigid Endoscopes Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Laparoscopes, Arthroscopes, Ureteroscopes, Cystoscopes, Gynecology Endoscopes, Neuroendoscopes, Bronchoscopes, Hysteroscopes, Laryngoscopes, Sinuscopes, Otoscopes, Sigmoidoscopes, Pharygnoscopes, Duodenoscopes, Nasopharygnoscopes, Rhinoscopes)
  • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Rigid Endoscopes Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Rigid Endoscopes Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Rigid Endoscopes Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Rigid Endoscopes Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End User

7. Europe Rigid Endoscopes Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Rigid Endoscopes Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End User
  • 7.3.2. France Rigid Endoscopes Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Rigid Endoscopes Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Rigid Endoscopes Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Rigid Endoscopes Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End User

8. Asia Pacific Rigid Endoscopes Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Rigid Endoscopes Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End User
  • 8.3.2. India Rigid Endoscopes Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Rigid Endoscopes Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Rigid Endoscopes Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Rigid Endoscopes Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End User

9. Middle East & Africa Rigid Endoscopes Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Rigid Endoscopes Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Rigid Endoscopes Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Rigid Endoscopes Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End User

10. South America Rigid Endoscopes Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Rigid Endoscopes Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Rigid Endoscopes Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Rigid Endoscopes Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Rigid Endoscopes Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Olympus Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Ethicon, Inc.
• 15.3. Boston Scientific Corporation
• 15.4. Karl Storz SE & Co. KG
• 15.5. Stryker Corporation
• 15.6. PENTAX Medical Singapore Pte Ltd
• 15.7. Richard Wolf GmbH
• 15.8. ATMOS MedizinTechnik GmbH & Co. KG
• 15.9. XION GmbH
• 15.10. EndoMed Systems GmbH

16. Strategic Recommendations

17. About Us & Disclaimer